AllianceBernstein’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-107,400
| Closed | -$2.03M | – | 3184 |
|
|
2019
Q3 | $2.03M | Hold |
107,400
| – | – | ﹤0.01% | 1897 |
|
|
2019
Q2 | $1.26M | Buy |
107,400
+4,000
| +4% | +$47.1K | ﹤0.01% | 2205 |
|
|
2019
Q1 | $1.41M | Sell |
103,400
-150,000
| -59% | -$2.05M | ﹤0.01% | 2086 |
|
|
2018
Q4 | $2.6M | Buy |
253,400
+150,000
| +145% | +$1.54M | ﹤0.01% | 1682 |
|
|
2018
Q3 | $1.72M | Hold |
103,400
| – | – | ﹤0.01% | 2030 |
|
|
2018
Q2 | $1.63M | Buy |
103,400
+18,294
| +21% | +$289K | ﹤0.01% | 2053 |
|
|
2018
Q1 | $1.08M | Sell |
85,106
-97,634
| -53% | -$1.24M | ﹤0.01% | 2207 |
|
|
2017
Q4 | $2.09M | Buy |
182,740
+116,600
| +176% | +$1.33M | ﹤0.01% | 1819 |
|
|
2017
Q3 | $810K | Sell |
66,140
-1,412,476
| -96% | -$17.3M | ﹤0.01% | 2367 |
|
|
2017
Q2 | $16.9M | Buy |
1,478,616
+48,817
| +3% | +$559K | 0.01% | 803 |
|
|
2017
Q1 | $29.7M | Sell |
1,429,799
-119,643
| -8% | -$2.49M | 0.02% | 615 |
|
|
2016
Q4 | $32.2M | Buy |
1,549,442
+221,880
| +17% | +$4.62M | 0.03% | 571 |
|
|
2016
Q3 | $43.5M | Sell |
1,327,562
-41,156
| -3% | -$1.35M | 0.04% | 485 |
|
|
2016
Q2 | $34.2M | Sell |
1,368,718
-224,189
| -14% | -$5.6M | 0.03% | 527 |
|
|
2016
Q1 | $39M | Buy |
1,592,907
+115,778
| +8% | +$2.84M | 0.03% | 489 |
|
|
2015
Q4 | $48.8M | Sell |
1,477,129
-3,397
| -0.2% | -$112K | 0.04% | 448 |
|
|
2015
Q3 | $48.5M | Buy |
1,480,526
+160,417
| +12% | +$5.26M | 0.04% | 440 |
|
|
2015
Q2 | $69.9M | Sell |
1,320,109
-4,272
| -0.3% | -$226K | 0.06% | 375 |
|
|
2015
Q1 | $38.2M | Buy |
1,324,381
+1,320,481
| +33,858% | +$38.1M | 0.03% | 542 |
|
|
2014
Q4 | $113K | Sell |
3,900
-1,300
| -25% | -$37.7K | ﹤0.01% | 2957 |
|
|
2014
Q3 | $66K | Sell |
5,200
-1,100
| -17% | -$14K | ﹤0.01% | 3032 |
|
|
2014
Q2 | $126K | Buy |
+6,300
| New | +$126K | ﹤0.01% | 2930 |
|